Fundz

Liquidia Corporation Appoints Russell Schundler as Chief Strategy Officer and General Counsel

PUBLIC · LQDANov 19, 2026
Internal move“Mr. Schundler has held the position of General Counsel at the company since March 2021.”

Position

General Counsel

Company

Liquidia

Russell Schundler
MorrisvilleManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalBiotechnology Research

Description

On November 12, 2026, Liquidia Corporation appointed Russell Schundler as its Chief Strategy Officer and General Counsel, effective November 16, 2026. Mr. Schundler has held the position of General Counsel at the company since March 2021

Quick answer

Liquidia Corporation Appoints Russell Schundler as Chief Strategy Officer and General Counsel (November 19, 2026). Liquidia is based in Morrisville, North Carolina, United States.

Who is the new General Counsel at Liquidia?
Liquidia named Russell Schundler General Counsel, announced November 19, 2026.
What did Liquidia announce on November 19, 2026?
On November 12, 2026, Liquidia Corporation appointed Russell Schundler as its Chief Strategy Officer and General Counsel, effective November 16, 2026.
What does Liquidia do?
Liquidia is a biopharmaceutical company focused on the development and commercialization of products that address unmet patient needs, with current focus directed towards the treatment of pulmonary arterial hypertension...
Where is Liquidia based?
Liquidia is based in Morrisville, North Carolina, United States.
Which similar companies made leadership changes around the same time?
Teva Pharmaceutical Industries Ltd (November 19, 2026), Bristol Myers Squibb (November 15, 2026), Cerenome, Inc. (November 12, 2026) and AbbVie Inc. (November 2, 2026) also announced leadership changes within 45 days of Liquidia.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Liquidia, and when

A new leader at Liquidia brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Liquidia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Liquidia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Liquidia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Liquidia

Location

419 Davis Drive, Suite 100

Morrisville, North Carolina, United States

About

Liquidia is a biopharmaceutical company focused on the development and commercialization of products that address unmet patient needs, with current focus directed towards the treatment of pulmonary arterial hypertension (PAH). Our pipeline is focused on the development of two product candidates using our PRINT® Technology platform: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Our subsidiary, Liquidia PAH (formerly RareGen), generates revenue pursuant to a promotional agreement between RareGen and Sandoz, sharing profit derived from the sale of the first-to-file fully substitutable generic treprostinil injection, or Treprostinil Injection, in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Liquidia changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

ROGER
Senior decision-maker at this company
••••••••@••••••••

See ROGER's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Liquidia's next move

Learn about Strategic plan

Liquidia changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.